Edwards Lifesciences Corp

Name: Edwards Lifesciences Corp insider trading (SEC Form 4) history
Creator: U.S. Securities and Exchange Commission

SEC CIK 1099800

$90.78 +14.9% · 90 days

90-day buys

0 open-market

90-day sells

$7.67M

12 open-market

Net insider flow

−$7.67M

Net selling

Filings shown

Most recent

At a glance

Over the last 90 days, insiders at EW have sold a net $7.67M of stock (0 open-market buys vs 12 sells).

Largest recent trade: Zovighian Bernard J sold $2.77M of EW, trimming their stake 75%.

Most active filer: Ullem Scott B., with 27 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for EW, newest first

View on SEC EDGAR ↗

Edwards Lifesciences Corp

Sell Zovighian Bernard J · Director, CEO · Open-market sale · filed May 6, 2025 ΔOwn −9.3%

Zovighian Bernard J sold $448K of EW, trimming their stake 9%.

−$448K

5,980 sh @ $75

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Mar 26, 2025 ΔOwn −27%

Ullem Scott B. sold $797.3K of EW, trimming their stake 27%.

−$797.3K

11,250 sh @ $71

Edwards Lifesciences Corp

Sell Zovighian Bernard J · Director, CEO · Open-market sale · filed Mar 10, 2025 ΔOwn −9.4%

Zovighian Bernard J sold $428.4K of EW, trimming their stake 9%.

−$428.4K

6,164 sh @ $70

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Feb 28, 2025 ΔOwn −8.4%

Ullem Scott B. sold $249.1K of EW, trimming their stake 8%.

−$249.1K

3,490 sh @ $71

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Feb 28, 2025 ΔOwn −20%

Ullem Scott B. sold $547.2K of EW, trimming their stake 20%.

−$547.2K

7,760 sh @ $71

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Feb 13, 2025 ΔOwn −27%

Ullem Scott B. sold $852.3K of EW, trimming their stake 27%.

−$852.3K

11,250 sh @ $76

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Dec 9, 2024 ΔOwn −27%

Ullem Scott B. sold $806.4K of EW, trimming their stake 27%.

−$806.4K

11,250 sh @ $72

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Jun 20, 2024 ΔOwn −1.1%

Ullem Scott B. sold $35.2K of EW, trimming their stake 1%.

−$35.2K

400 sh @ $88

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Jun 20, 2024 ΔOwn −15%

Ullem Scott B. sold $457K of EW, trimming their stake 15%.

−$457K

5,225 sh @ $87

Edwards Lifesciences Corp

Sell Zovighian Bernard J · Director, CEO · Open-market sale · filed May 30, 2024 ΔOwn −11%

Zovighian Bernard J sold $755.5K of EW, trimming their stake 11%.

−$755.5K

8,617 sh @ $88

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed May 21, 2024 ΔOwn −16%

Ullem Scott B. sold $508.8K of EW, trimming their stake 16%.

−$508.8K

5,625 sh @ $90

Edwards Lifesciences Corp

Buy Zovighian Bernard J · Director, CEO · Open-market purchase · filed May 7, 2024 ΔOwn +22%

Zovighian Bernard J, EW's CEO, spent $49.8K of their own money on 580 shares at $86, growing their stake 22%.

+$49.8K

580 sh @ $86

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Apr 30, 2024 ΔOwn −2.7%

Ullem Scott B. sold $60.5K of EW, trimming their stake 3%.

−$60.5K

700 sh @ $86

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Apr 30, 2024 ΔOwn −26%

Ullem Scott B. sold $561.6K of EW, trimming their stake 26%.

−$561.6K

6,550 sh @ $86

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Apr 1, 2024 ΔOwn −3.3%

Ullem Scott B. sold $82.9K of EW, trimming their stake 3%.

−$82.9K

868 sh @ $96

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Apr 1, 2024 ΔOwn −25%

Ullem Scott B. sold $605.5K of EW, trimming their stake 25%.

−$605.5K

6,387 sh @ $95

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Feb 29, 2024 ΔOwn −28%

Ullem Scott B. sold $620.9K of EW, trimming their stake 28%.

−$620.9K

7,255 sh @ $86

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Feb 1, 2024 ΔOwn −27%

Ullem Scott B. sold $568K of EW, trimming their stake 27%.

−$568K

7,255 sh @ $78

Edwards Lifesciences Corp

Sell Ullem Scott B. · CVP, Chief Financial Officer · Open-market sale · filed Dec 29, 2023 ΔOwn −43%

Ullem Scott B. sold $1.11M of EW, trimming their stake 43%.

−$1.11M

14,510 sh @ $77

Edwards Lifesciences Corp

Sell Zovighian Bernard J · CVP, TMTT · Open-market sale · filed Aug 5, 2022 ΔOwn −18%

Zovighian Bernard J sold $498.7K of EW, trimming their stake 18%.

−$498.7K

4,811 sh @ $104

Edwards Lifesciences Corp

Sell Zovighian Bernard J · CVP, TMTT · Open-market sale · filed Jun 14, 2022 ΔOwn −16%

Zovighian Bernard J sold $422K of EW, trimming their stake 16%.

−$422K

4,809 sh @ $88

Edwards Lifesciences Corp

Sell Zovighian Bernard J · CVP, TMTT · Open-market sale · filed May 31, 2022 ΔOwn −23%

Zovighian Bernard J sold $907.5K of EW, trimming their stake 23%.

−$907.5K

9,000 sh @ $101

Edwards Lifesciences Corp

Sell Zovighian Bernard J · CVP, TMTT · Open-market sale · filed May 24, 2022 ΔOwn −11%

Zovighian Bernard J sold $459.4K of EW, trimming their stake 11%.

−$459.4K

4,809 sh @ $96

About EW insider activity

This page tracks every recent Form 4 filed for Edwards Lifesciences Corp with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is EW insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Edwards Lifesciences Corp usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.